In the present study, we enriched the metabolic pathway, glutathione, by metabolomics analysis, and due to the dysregulation of the glutathione metabolic pathway, the expression of Nrf2 was reduced in ovarian cancer cells in the combination group compared with the control group and the single-agent group (Figures 4L,M). Here, NFE2L2 is linked to ovarian carcinoma.